Latest Asx News

Capricorn Metals has fully repaid its remaining $50 million corporate debt ahead of schedule, positioning itself as debt and gold hedging free with strong cash reserves to back growth projects.

GTN Limited is set to seek shareholder approval for a substantial $44 million capital return, aiming to reward investors without compromising its dividend policy.

GTN Limited has revised down its FY25 revenue and adjusted EBITDA guidance, citing one-off corporate expenses and strategic investments, while maintaining strong cash flow and capital management plans.

Global X Management (AUS) Limited has updated the estimated distribution for its Ultra Long Nasdaq 100 Complex ETF, setting it at just over 54 cents per unit for the June 2025 period. Key dates for distribution and dividend reinvestment plan participation are now confirmed.

Aerometrex has renewed and extended its multi-million dollar agreement with Landchecker, significantly increasing its annual recurring revenue through the MetroMap platform.

Mineral Commodities Ltd has extended the maturity date of its A$2.4 million convertible loan facility, tying repayment timing to the potential sale of its Skaland asset. This move provides the company with greater financial flexibility as it navigates strategic asset sales.

GBM Resources has completed the first tranche of its capital raising, issuing nearly 245 million shares at $0.006 each, while the second tranche and additional securities await shareholder approval.

Silk Logistics Holdings and DP World Australia have agreed to push back the deadline for their acquisition deal, awaiting a key regulatory decision from the ACCC.

Andromeda Metals has launched a $5 million capital raising via a Placement, accompanied by Placement and Broker Options, to advance its flagship Great White Project and High Purity Alumina development.

Microba Life Sciences invites eligible shareholders to participate in a $2 million Share Purchase Plan at $0.09 per share, matching recent institutional pricing and including free attaching options. The capital raise aims to accelerate clinical adoption and push the company towards regional break-even.

Microba Life Sciences has announced a $14.5 million capital raising, including a $2 million fully underwritten Securities Purchase Plan (SPP) and a $12.5 million Placement, aimed at fast-tracking commercialisation of its microbiome diagnostic tests in Australia and the UK.

Anagenics Limited’s licensed brand Bouf Haircare is outperforming expectations with strong early sales and promising royalty returns, signaling robust growth potential for the company’s intellectual property portfolio.